Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000251805 (LOC124900541) is classified as a non-protein coding RNA gene of the scaRNA type, which typically guides chemical modifications of spliceosomal RNAs within the Cajal bodies of the nucleus[1]. There is no evidence for protein coding, therapeutic targeting, involvement in major diseases, or use as a clinical biomarker; it is annotated based on genomic position and noncoding RNA characteristics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Cajal body-specific RNA (scaRNA).